Invest-CTO PCI Trial
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Anja Øksnes, MD
Haukeland University Hospital
Principal Investigator - Margaret B Mcentegart, PhD
Golden Jubilee National Hospital
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Haukeland University Hospital
Bergen, Bergen, Norway
- Golden Jubilee National Hospital
Glasgow, Glasgow, United Kingdom
- Bristol Health
Bristol, United Kingdom
- St George´s Hospital
London, United Kingdom
- Columbia University Medical Center/ Newyork Presbyterian Hospital
New York, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Dec 2021
- Primary completion
- 9 Oct 2025
- Completion
- 31 Oct 2026
- Last update posted
- 21 Nov 2025
- Registered enrollment
- 200
- Registry id
- NCT04774913
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.